Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma

No abstract is available for this paper.

• Publication year

  1985

• Venue

  International Journal of Cancer

• Publication date

  1985-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.2910350404PMID 2985508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for the detection of the normal counterpart of hodgkin and sternberg‐reed cells

  2007cited by this paper
• Burkitt's lymphoma.

  1986cited by this paper
• Characterization of a Human B Lymphocyte-Specific Antigen Defined by Monoclonal Antibodies HD6 and HD39

  1986cited by this paper
• Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.

  1985cited by this paper
• Paired epstein‐barr virus‐carrying lymphoma and lymphoblastoid cell lines Burkitt's lymphoma patients: Comparative sensitivity to non‐specific and to allo‐specific cytotoxic responses in vitro

  1984cited by this paper
• Human B Cell and B Cell Blast-Associated Surface Molecules Defined with Monoclonal Antibodies

  1984cited by this paper
• Molecular aspects of immunoglobulin expression by human B cell leukemias and lymphomas.

  1984cited by this paper
• Possible duality in Burkitt lymphoma origin.

  1984cited by this paper
• Distinction between burkitt lymphoma subgroups by monoclonal antibodies: Relationships between antigen expression and type of chromosomal translocation

  1984cited by this paper
• Expression of the bla antigen, defined by the monoclonal 38.13 antibody, on burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other b‐cell lymphomas and leukemias

  1983cited by this paper
• A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody.

  1983cited by this paper
• Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings.

  1983cited by this paper
• Internal mammary lymphoscintigraphy: current status in the treatment of breast cancer.

  1983cited by this paper
• Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma.

  1982cited by this paper
• A DIFFERENTIATION ANTIGEN EXPRESSED SELECTIVELY BY A PROPORTION OF HUMAN BLOOD CELLS: DETECTION WITH A MONOCLONAL ANTIBODY

  1982cited by this paper
• Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

  1982cited by this paper
• Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma

  1982cited by this paper
• Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy.

  1982cited by this paper
• B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.

  1982cited by this paper
• Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.

  1982cited by this paper
• Monoclonal antibodies to epstein‐barr virus‐induced, transformation‐associated cell surface antigens: Binding patterns and effect upon virus‐specific t‐cell cytotoxicity

  1982cited by this paper
• Neutrophil granulocytic cell antigen defined by a monoclonal antibody--its distribution within normal haemic and non-haemic tissue.

  1982cited by this paper
• Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

  1982cited by this paper
• Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

  1982cited by this paper
• Interaction of Epstein‐Barr virus with leukaemic B cells in vitro. II. Cell line establishment from prolymphocytic leukaemia and from Waldenström's macroglobulinaemia

  1982cited by this paper
• Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children.

  1982cited by this paper
• Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.

  1981cited by this paper
• Monoclonal antibody against a Burkitt lymphoma-associated antigen.

  1981cited by this paper
• Burkitt's lymphoma

  1981cited by this paper
• Characterization of a human B cell-specific antigen (B2) distinct from B1.

  1981cited by this paper
• Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes.

  1981cited by this paper
• A monoclonal antibody to human acute lymphoblastic leukaemia antigen

  1980cited by this paper
• Characterization of a human B lymphocyte-specific antigen.

  1980cited by this paper
• The Relationship of the Virus to Burkitt’s Lymphoma

  1979cited by this paper
• Murine Monoclonal Antibodies against HLA Structures

  1979cited by this paper
• Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

  1978cited by this paper
• Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

  1978cited by this paper
• Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience.

  1977cited by this paper
• Differences in the ConA-induced redistribution and agglutination patterns of EBV genome-free and EBV-carrying human lymphoma lines.

  1977cited by this paper
• Epstein-Barr virus (EBV)-induced change in the saturation sensitivity and serum dependence of established, EBV-negative lymphoma lines in vitro.

  1976cited by this paper
• Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro.

  1975cited by this paper
• Letter: Screening for neural-tube defects.

  1975cited by this paper
• Oncogenic Herpes viruses.

  1975cited by this paper
• Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines

  1973cited by this paper
• Etiology of Burkitt's lymphoma--an alternative hypothesis to a vectored virus.

  1969cited by this paper
• Burkitt's lymphoma outside the known endemic areas of Africa and New Guinea

  1967cited by this paper

• Assessing the fitness of Epstein-Barr virus following its reactivation

  2025cites this paper
• Mosaic chromosomal alterations in peripheral blood leukocytes of children in sub-Saharan Africa

  2023cites this paper
• Systematic analysis of Epstein-Barr virus genes and their individual contribution to virus production and composition

  2021cites this paper
• Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids

  2021cites this paper
• Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus

  2020influential citation
• Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs

  2019cites this paper
• The first days in the life of naïve human B-lymphocytes infected with Epstein-Barr virus

  2019cites this paper
• First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus

  2019cites this paper
• Investigating the anti-apoptotic role of EBV in endemic Burkitt lymphona

  2015cites this paper
• Primary immunodeficiencies and the control of Epstein–Barr virus infection

  2015cites this paper
• EBV-Specific Immune Response: Early Research and Personal Reminiscences.

  2015cites this paper
• Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory.

  2014cites this paper
• Mechanisms of microenvironmental conditioning in non-Hodgkin’s lymphoma

  2012cites this paper
• Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies

  2012cites this paper
• Epstein-Barr virus genome loss from Endemic Burkitt lymphoma and its effect on cell phenotype

  2009cites this paper
• Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.

  2009cites this paper
• Mechanisms involved in Burkitt's tumor formation.

  2008cites this paper
• Mechanisms involved in Burkitt’s lymphoma tumor formation

  2008cites this paper
• The B Cell Antigen Receptor and Overexpression of MYC Can Cooperate in the Genesis of B Cell Lymphomas

  2008cites this paper
• New Type B Isolates of Epstein-Barr Virus from Burkitt ' s Lymphoma and from Normal Individuals in Endemic Areas

  2007cites this paper
• Epstein–Barr virus and Burkitt lymphoma

  2007cites this paper
• LOCAL GROWTH OF A BURKITT’S LYMPHOMA E R S U S DISSEMINATED LYMPHOBLASTOID CELLS AND THEIR SOMATIC CELL HYBRIDS IN SCID MICE INVASIVE GROWTH OF THE AUTOLOGOUS EBV-IMMORTALIZED

  2006cites this paper
• Distribution of the Burkitt's lymphoma-associated antigen (BLA) in normal human tissue and malignant lymphoma as defined by immunohistological staining with monoclonal antibody 38.13

  2004cites this paper
• SH2D1 AEXPRESSIO NI NBURKIT TLYMPHOM ACELL SI SRESTRICTE DTO EB VPOSITIV EGROU PI LINE SAN DI SDOWNREGULATE DI NPARALLEL WIT HIMMUNOBLASTI CTRANSFORMATION

  2002cites this paper
• The Metastatic Suppressor Nm23-H1 Interacts with EBNA3C at Sequences Located between the Glutamine- and Proline-Rich Domains and Can Cooperate in Activation of Transcription

  2002cites this paper
• SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation

  2002cites this paper
• Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1

  2001cites this paper
• Infections as a major preventable cause of human cancer

  2001cites this paper
• Characterization of the Human FLICE‐Inhibitory Protein Locus and Comparison of the Anti‐Apoptotic Activity of Four Different FLIP Isoforms

  2001cites this paper
• Promoter-Proximal Regulatory Elements Involved in oriP-EBNA1-Independent and -Dependent Activation of the Epstein-Barr Virus C Promoter in B-Lymphoid Cell Lines

  2001cites this paper
• Infections as a major preventable cause of human cancer

  2000cites this paper
• The generation and in vitro characterisation of EBV B-LCL x melanoma hybrid cells as potential candidates in tumour immunotherapy

  2000cites this paper
• Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease.

  2000cites this paper
• Epstein-Barr Virus Nuclear Antigen 1 Sequences in Endemic and Sporadic Burkitt’s Lymphoma Reflect Virus Strains Prevalent in Different Geographic Areas

  1999cites this paper
• Establishment and characterization of a novel ALL-L3 cell line (BALM-18): induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells.

  1999cites this paper
• Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand.

  1998cites this paper
• Prolonged Phenotypic, Functional, and Molecular Change in Group I Burkitt Lymphoma Cells on Short-Term Exposure to CD40 Ligand

  1998cites this paper
• Identification of a Cytotoxic T-Lymphocyte Response to the Novel BARF0 Protein of Epstein-Barr Virus: a Critical Role for Antigen Expression

  1998cites this paper
• Expression of the Epstein-Barr virus protein LMP1 mediates tumor regression in vivo.

  1998cites this paper
• Water-related carcinomas : Environmental classification

  1997cites this paper
• Epstein-Barr virus infection and the pathogenesis of malignant lymphomas.

  1997cites this paper
• Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.

  1996cites this paper
• Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.

  1996cites this paper
• Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias

  1996cites this paper
• Fusaproliferin production by Fusarium subglutinans and its toxicity to Artemia salina, SF-9 insect cells, and IARC/LCL 171 human B lymphocytes

  1996cites this paper
• Histopathology of Non-Hodgkin’s Malignant Lymphomas

  1995cites this paper
• Sequential changes in glycolipid expression during human B cell differentiation: enzymatic bases.

  1995cites this paper
• Epstein-Barr Virus and Lymphomas: An Overview

  1995cites this paper
• Differential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt's lymphoma cell lines

  1995cites this paper
• Lymphotoxin acts as an autocrine growth factor for Epstein‐Barr virus‐transformed B cells and differentiated Burkitt lymphoma cell lines

  1994cites this paper
• Lymphomas of the head and neck. 2; The B-cell lymphomas.

  1994cites this paper
• Epstein-Barr virus-carrying B cells are large, surface IgM, IgD-bearing cells in normal individuals and acute malaria patients.

  1994cites this paper
• Biased utilization of immunoglobulin variable region heavy‐ and light‐chain genes by the malignant CD5‐ B lymphocytes from patients with Burkitt's lymphoma

  1994cites this paper
• The epstein‐barr virus latent membrane protein‐1 (LMP1) induces interleukin‐10 production in burkitt lymphoma lines

  1994cites this paper
• Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.

  1994cites this paper
• Gene Expression in Burkitt’s Lymphoma Cells

  1994cites this paper
• Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.

  1993cites this paper
• Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.

  1993cites this paper
• HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.

  1993cites this paper
• The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma.

  1993cites this paper
• Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.

  1993cites this paper
• Modulation of expression of insulin and IGF‐I receptor by Epstein‐Barr virus and its gene products LMP and EBNA‐2 in lymphocyte cell lines

  1993cites this paper
• Antigen processing and presentation by EBV‐carrying cell lines: Cell‐phenotype dependence and influence of the EBV‐encoded LMP1

  1993cites this paper
• Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors

  1993cites this paper
• E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development

  1993cites this paper
• Transformation‐Associated Epstein‐Barr Virus Antigens as Targets for Immune Attack a

  1993cites this paper
• Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.

  1993cites this paper
• Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV‐immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice

  1992cites this paper
• Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines

  1992cites this paper
• Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.

  1992cites this paper
• Expression of the epstein‐barr virus (EBV)‐encoded membrane protein LMP1 impairs the In vitro growth, clonability and tumorigenicity of an EBV‐negative burkitt lymphoma line

  1992cites this paper
• Infektionen durch Epstein-Barr- und Zytomegalievirus

  1992cites this paper
• T cell recognition of Epstein-Barr virus associated lymphomas.

  1992cites this paper
• [Epstein-Barr virus infection--a lympho- and epitheliotropic infection].

  1992cites this paper
• Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration.

  1992cites this paper
• CD 30 expression in follicular lymphoma

  1991cites this paper
• Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

  1991cites this paper
• Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.

  1991cites this paper
• Control of c-myc regulation in normal and neoplastic cells.

  1991cites this paper
• Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene

  1991cites this paper
• Immune Response Directed Against Epstein-Barr Virus Carrier B Lymphocytes

  1991cites this paper
• Advances in the Understanding of EBV Associated Lymphoproliferative Disorders

  1991cites this paper
• Sequential shifts in the three major glycosphingolipid series are associated with B cell differentiation.

  1991cites this paper
• Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis

  1991cites this paper
• Expression of Ki‐1 antigen (CD30) in mesenchymal tumors

  1990cites this paper
• CD30 expression in non‐Hodgkin's lymphoma

  1990cites this paper
• Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.

  1990cites this paper
• The pathogenesis of Burkitt's lymphoma.

  1990cites this paper
• Expression of the Epstein‐Barr virus (EBV)‐encoded membrane antigen (LMP) increases the stimulatory capacity of EBV‐negative B lymphoma lines in allogeneic mixed lymphocyte cultures

  1990cites this paper
• 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael

  1989cites this paper
• Viral latency and transformation: the strategy of Epstein-Barr virus.

  1989cites this paper
• Insulin receptor expression in burkitt lymphoma cell lines

  1989cites this paper
• Reversion of tumorigenicity in an EBV-converted Burkitt's lymphoma line.

  1989cites this paper
• CD30(Ki-1) antigen expression in a subset of gastric mucosal plasma cells and in a primary gastric plasmacytoma.

  1989cites this paper
• Characterization of immunoglobulin mrna expression in burkitt lymphoma cell lines

  1989cites this paper
• Epstein-Barr Virus Gene Expression in Normal and Malignant B Cells: Implications for the Immune T Cell Control of EBV Infection

  1989cites this paper
• Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization.

  1989cites this paper
• Monoclonal antibody against a melanosomal protein in melanotic and amelanotic human melanoma cells.

  1989cites this paper
• Immunophenotypic characterization of follicle‐center‐cell‐derived non‐hodgkin's lymphomas

  1989cites this paper
• Identification of a human epithelial cell surface protein sharing an epitope with the C3d/epstein‐barr virus receptor molecule of B lymphocytes

  1989cites this paper